An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

Exclusion Criteria

• •Each outcome will be analyzed separately as time to first event, thus people who experience an outcome prior to their study start date are ineligible for analyses related to that particular outcome.
• •Achieved SVR-12 prior to index date
• •HCV treatment experienced prior to index date
• •No visit in GI, Infectious Disease, or Liver Transplant / Hepatology
• •No positive HCV test (genotype, viral load, or qualitative)
• •No recent positive HCV test (genotype, viral load or qualitative)